156 related articles for article (PubMed ID: 8387763)
21. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
Yamada M; Yamada M; Watson MA; Richelson E
Mol Pharmacol; 1994 Sep; 46(3):470-6. PubMed ID: 7935327
[TBL] [Abstract][Full Text] [Related]
22. Proteinase-activated receptor-2-mediated signaling and inhibition of DNA synthesis in human pancreatic cancer cells.
Kaufmann R; Schafberg H; Nowak G
Int J Pancreatol; 1998 Oct; 24(2):97-102. PubMed ID: 9816542
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer.
Swift IR; Smith JP
Dig Dis Sci; 1994 May; 39(5):1007-13. PubMed ID: 8174413
[TBL] [Abstract][Full Text] [Related]
24. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Murata T
Int J Mol Med; 2015 Jun; 35(6):1773-8. PubMed ID: 25847529
[TBL] [Abstract][Full Text] [Related]
25. Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines.
Douziech N; Lajas A; Coulombe Z; Calvo E; Lainé J; Morisset J
Endocrine; 1998 Oct; 9(2):171-83. PubMed ID: 9867251
[TBL] [Abstract][Full Text] [Related]
26. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
Slusher BS; Zacco AE; Maslanski JA; Norris TE; McLane MW; Moore WC; Rogers NE; Ignarro LJ
Mol Pharmacol; 1994 Jul; 46(1):115-21. PubMed ID: 7520123
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of anchorage-independent growth of human pancreatic carcinoma MIA PaCa-2 cells by signaling from protein kinase C to mitogen-activated protein kinase.
Ishino K; Fukazawa H; Shikano M; Ohba M; Kuroki T; Uehara Y
Mol Carcinog; 2002 Aug; 34(4):180-6. PubMed ID: 12203369
[TBL] [Abstract][Full Text] [Related]
28. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibitory effect of L-canavanine against MIA PaCa-2 pancreatic cancer cells is not due to conversion to its toxic metabolite canaline.
Swaffar DS; Ang CY
Anticancer Drugs; 1999 Jan; 10(1):113-8. PubMed ID: 10194554
[TBL] [Abstract][Full Text] [Related]
30. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations.
Seethalakshmi L; Mitra SP; Dobner PR; Menon M; Carraway RE
Prostate; 1997 May; 31(3):183-92. PubMed ID: 9167771
[TBL] [Abstract][Full Text] [Related]
31. Effect of 5-HT3 receptor antagonist (ondansetron) on functioning human pancreatic carcinoid cells.
Ishizuka J; Hsieh AC; Townsend CM; Thompson JC
Surg Oncol; 1993 Aug; 2(4):221-5. PubMed ID: 8252212
[TBL] [Abstract][Full Text] [Related]
32. Cyclic adenosine 5'-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways.
Li J; O'Connor KL; Cheng X; Mei FC; Uchida T; Townsend CM; Evers BM
Mol Endocrinol; 2007 Jan; 21(1):159-71. PubMed ID: 17068197
[TBL] [Abstract][Full Text] [Related]
33. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
Hassan S; Dobner PR; Carraway RE
Regul Pept; 2004 Aug; 120(1-3):155-66. PubMed ID: 15177934
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of calcium channel blockers on growth of pancreatic cancer cells.
Sato K; Ishizuka J; Cooper CW; Chung DH; Tsuchiya T; Uchida T; Rajaraman S; Townsend CM; Thompson JC
Pancreas; 1994 Mar; 9(2):193-202. PubMed ID: 8190721
[TBL] [Abstract][Full Text] [Related]
35. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
Lin CW; Miller TR; Witte DG; Bianchi BR; Stashko M; Manelli AM; Frail DE
Mol Pharmacol; 1995 Jan; 47(1):131-9. PubMed ID: 7838121
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A.
Farrow B; Rychahou P; Murillo C; O'connor KL; Iwamura T; Evers BM
Surgery; 2003 Aug; 134(2):197-205. PubMed ID: 12947318
[TBL] [Abstract][Full Text] [Related]
37. Neurotensin is a regulator of insulin secretion in pancreatic beta-cells.
Béraud-Dufour S; Abderrahmani A; Noel J; Brau F; Waeber G; Mazella J; Coppola T
Int J Biochem Cell Biol; 2010 Oct; 42(10):1681-8. PubMed ID: 20601081
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal hormones and cell proliferation.
Townsend CM; Bold RJ; Ishizuka J
Surg Today; 1994; 24(9):772-7. PubMed ID: 7865952
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of signal transduction mechanisms for the mitogenic effects of prostaglandin E2 in normal human bone cells in vitro.
Baylink TM; Mohan S; Fitzsimmons RJ; Baylink DJ
J Bone Miner Res; 1996 Oct; 11(10):1413-8. PubMed ID: 8889840
[TBL] [Abstract][Full Text] [Related]
40. Haloperidol induces demethylation and expression of the dual specificity phosphatase 6 gene in MIA PaCa-2 human pancreatic cancer cells.
Kim SH; Lee HY; Yi H; Ahn YM; Kim YS
Life Sci; 2012 Dec; 91(25-26):1317-22. PubMed ID: 23063941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
